About INNOVENE, INC.
Innovene Therapeutics is a biotechnology company focused on developing precision small-molecule therapies for HPV-related diseases, with a lead candidate, Seravyn (INV-015), in preclinical development. The company is driven by NIH-supported research and aims to address the unmet medical need for HPV treatment.
Development of precision small-molecule combinations targeting HPV biologyDesign of self-administered topical therapies for HPV-related diseasesPreclinical research supported by NIH/NIAID programsFormulation of proprietary topical creams with self-emulsifying systemsIn vivo evaluation in biologically relevant papillomavirus models
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to INNOVENE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.